nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—AR—scrotum—sarcoma	0.0354	0.116	CbGeAlD
Danazol—SHBG—hindlimb—sarcoma	0.0168	0.0552	CbGeAlD
Danazol—ESR1—periosteum—sarcoma	0.0166	0.0546	CbGeAlD
Danazol—CYP3A4—Thiotepa—sarcoma	0.0155	0.458	CbGbCtD
Danazol—CCL2—endothelium—sarcoma	0.0149	0.049	CbGeAlD
Danazol—CCL2—myometrium—sarcoma	0.00852	0.028	CbGeAlD
Danazol—CCL2—embryo—sarcoma	0.0082	0.0269	CbGeAlD
Danazol—CCL2—seminal vesicle—sarcoma	0.0077	0.0253	CbGeAlD
Danazol—CCL2—hematopoietic system—sarcoma	0.00732	0.024	CbGeAlD
Danazol—CCL2—connective tissue—sarcoma	0.00705	0.0231	CbGeAlD
Danazol—CYP3A4—Mitoxantrone—sarcoma	0.00667	0.197	CbGbCtD
Danazol—CCL2—smooth muscle tissue—sarcoma	0.00645	0.0212	CbGeAlD
Danazol—CCL2—skin of body—sarcoma	0.00636	0.0209	CbGeAlD
Danazol—PGR—mammary gland—sarcoma	0.00631	0.0207	CbGeAlD
Danazol—CCL2—cardiac atrium—sarcoma	0.00556	0.0183	CbGeAlD
Danazol—CCL2—uterus—sarcoma	0.00553	0.0182	CbGeAlD
Danazol—CCL2—lymphoid tissue—sarcoma	0.00515	0.0169	CbGeAlD
Danazol—GNRHR—testis—sarcoma	0.00514	0.0169	CbGeAlD
Danazol—ESR1—mammary gland—sarcoma	0.00494	0.0162	CbGeAlD
Danazol—CCL2—tendon—sarcoma	0.00484	0.0159	CbGeAlD
Danazol—CCL2—bone marrow—sarcoma	0.00469	0.0154	CbGeAlD
Danazol—CYP3A4—Vincristine—sarcoma	0.00459	0.136	CbGbCtD
Danazol—PGR—myometrium—sarcoma	0.00448	0.0147	CbGeAlD
Danazol—SHBG—hematopoietic system—sarcoma	0.00427	0.014	CbGeAlD
Danazol—CYP3A4—Etoposide—sarcoma	0.00421	0.124	CbGbCtD
Danazol—SHBG—connective tissue—sarcoma	0.00411	0.0135	CbGeAlD
Danazol—CCL2—testis—sarcoma	0.00401	0.0132	CbGeAlD
Danazol—PGR—hematopoietic system—sarcoma	0.00385	0.0126	CbGeAlD
Danazol—CCL2—liver—sarcoma	0.00379	0.0125	CbGeAlD
Danazol—PGR—connective tissue—sarcoma	0.0037	0.0122	CbGeAlD
Danazol—AR—myometrium—sarcoma	0.00357	0.0117	CbGeAlD
Danazol—ESR1—myometrium—sarcoma	0.0035	0.0115	CbGeAlD
Danazol—CYP19A1—hematopoietic system—sarcoma	0.00346	0.0114	CbGeAlD
Danazol—PGR—smooth muscle tissue—sarcoma	0.00339	0.0111	CbGeAlD
Danazol—ESR1—embryo—sarcoma	0.00337	0.0111	CbGeAlD
Danazol—CYP19A1—connective tissue—sarcoma	0.00333	0.0109	CbGeAlD
Danazol—SHBG—uterus—sarcoma	0.00323	0.0106	CbGeAlD
Danazol—AR—seminal vesicle—sarcoma	0.00322	0.0106	CbGeAlD
Danazol—AR—hematopoietic system—sarcoma	0.00306	0.0101	CbGeAlD
Danazol—ESR1—hematopoietic system—sarcoma	0.00301	0.00988	CbGeAlD
Danazol—AR—connective tissue—sarcoma	0.00295	0.00969	CbGeAlD
Danazol—CCL2—lymph node—sarcoma	0.00291	0.00955	CbGeAlD
Danazol—PGR—uterus—sarcoma	0.00291	0.00954	CbGeAlD
Danazol—ESR1—connective tissue—sarcoma	0.0029	0.00951	CbGeAlD
Danazol—CYP3A4—Doxorubicin—sarcoma	0.00287	0.0848	CbGbCtD
Danazol—SHBG—bone marrow—sarcoma	0.00274	0.00899	CbGeAlD
Danazol—PGR—lymphoid tissue—sarcoma	0.00271	0.00889	CbGeAlD
Danazol—AR—smooth muscle tissue—sarcoma	0.0027	0.00887	CbGeAlD
Danazol—AR—skin of body—sarcoma	0.00266	0.00875	CbGeAlD
Danazol—ESR1—smooth muscle tissue—sarcoma	0.00265	0.0087	CbGeAlD
Danazol—CYP19A1—uterus—sarcoma	0.00262	0.00859	CbGeAlD
Danazol—SHBG—testis—sarcoma	0.00234	0.00769	CbGeAlD
Danazol—AR—cardiac atrium—sarcoma	0.00233	0.00764	CbGeAlD
Danazol—AR—uterus—sarcoma	0.00232	0.0076	CbGeAlD
Danazol—ESR1—uterus—sarcoma	0.00227	0.00746	CbGeAlD
Danazol—SHBG—liver—sarcoma	0.00221	0.00727	CbGeAlD
Danazol—AR—lymphoid tissue—sarcoma	0.00216	0.00709	CbGeAlD
Danazol—ESR1—lymphoid tissue—sarcoma	0.00212	0.00696	CbGeAlD
Danazol—PGR—testis—sarcoma	0.00211	0.00692	CbGeAlD
Danazol—AR—tendon—sarcoma	0.00203	0.00666	CbGeAlD
Danazol—CYP19A1—testis—sarcoma	0.0019	0.00623	CbGeAlD
Danazol—CYP19A1—liver—sarcoma	0.00179	0.00589	CbGeAlD
Danazol—AR—testis—sarcoma	0.00168	0.00552	CbGeAlD
Danazol—CYP3A4—hematopoietic system—sarcoma	0.00168	0.00551	CbGeAlD
Danazol—Dysphonia—Epirubicin—sarcoma	0.00167	0.00528	CcSEcCtD
Danazol—Acute coronary syndrome—Vincristine—sarcoma	0.00167	0.00527	CcSEcCtD
Danazol—Myocardial infarction—Vincristine—sarcoma	0.00166	0.00524	CcSEcCtD
Danazol—ESR1—testis—sarcoma	0.00165	0.00542	CbGeAlD
Danazol—Acute coronary syndrome—Mitoxantrone—sarcoma	0.00162	0.00514	CcSEcCtD
Danazol—Sweating—Vincristine—sarcoma	0.00162	0.00513	CcSEcCtD
Danazol—Myocardial infarction—Mitoxantrone—sarcoma	0.00161	0.00511	CcSEcCtD
Danazol—Erythema multiforme—Dactinomycin—sarcoma	0.00161	0.00508	CcSEcCtD
Danazol—Jaundice—Mitoxantrone—sarcoma	0.00161	0.00508	CcSEcCtD
Danazol—Cramp muscle—Etoposide—sarcoma	0.0016	0.00506	CcSEcCtD
Danazol—AR—liver—sarcoma	0.00159	0.00522	CbGeAlD
Danazol—Sweating—Mitoxantrone—sarcoma	0.00158	0.00499	CcSEcCtD
Danazol—Flushing—Dactinomycin—sarcoma	0.00158	0.00499	CcSEcCtD
Danazol—Haematuria—Mitoxantrone—sarcoma	0.00157	0.00497	CcSEcCtD
Danazol—Jaundice cholestatic—Epirubicin—sarcoma	0.00156	0.00494	CcSEcCtD
Danazol—Amenorrhoea—Epirubicin—sarcoma	0.00156	0.00494	CcSEcCtD
Danazol—ESR1—liver—sarcoma	0.00156	0.00512	CbGeAlD
Danazol—Dysphonia—Doxorubicin—sarcoma	0.00154	0.00488	CcSEcCtD
Danazol—Chills—Thiotepa—sarcoma	0.00154	0.00486	CcSEcCtD
Danazol—PGR—lymph node—sarcoma	0.00153	0.00502	CbGeAlD
Danazol—Chills—Dactinomycin—sarcoma	0.00152	0.00482	CcSEcCtD
Danazol—Alopecia—Thiotepa—sarcoma	0.00151	0.00478	CcSEcCtD
Danazol—Alopecia—Dactinomycin—sarcoma	0.0015	0.00475	CcSEcCtD
Danazol—Haemoglobin—Mitoxantrone—sarcoma	0.00149	0.0047	CcSEcCtD
Danazol—Haemorrhage—Mitoxantrone—sarcoma	0.00148	0.00468	CcSEcCtD
Danazol—Tension—Thiotepa—sarcoma	0.00146	0.00463	CcSEcCtD
Danazol—Nervousness—Thiotepa—sarcoma	0.00145	0.00458	CcSEcCtD
Danazol—Jaundice cholestatic—Doxorubicin—sarcoma	0.00145	0.00457	CcSEcCtD
Danazol—Amenorrhoea—Doxorubicin—sarcoma	0.00145	0.00457	CcSEcCtD
Danazol—Back pain—Thiotepa—sarcoma	0.00144	0.00456	CcSEcCtD
Danazol—Vision blurred—Thiotepa—sarcoma	0.0014	0.00444	CcSEcCtD
Danazol—CYP19A1—lymph node—sarcoma	0.00138	0.00452	CbGeAlD
Danazol—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00136	0.0043	CcSEcCtD
Danazol—Acute coronary syndrome—Etoposide—sarcoma	0.00135	0.00427	CcSEcCtD
Danazol—Myocardial infarction—Etoposide—sarcoma	0.00134	0.00425	CcSEcCtD
Danazol—Alopecia—Vincristine—sarcoma	0.00134	0.00424	CcSEcCtD
Danazol—Jaundice—Etoposide—sarcoma	0.00134	0.00422	CcSEcCtD
Danazol—Leukopenia—Thiotepa—sarcoma	0.00133	0.00422	CcSEcCtD
Danazol—Chills—Mitoxantrone—sarcoma	0.00133	0.0042	CcSEcCtD
Danazol—Leukopenia—Dactinomycin—sarcoma	0.00132	0.00419	CcSEcCtD
Danazol—Alopecia—Mitoxantrone—sarcoma	0.00131	0.00413	CcSEcCtD
Danazol—Fluid retention—Epirubicin—sarcoma	0.0013	0.00412	CcSEcCtD
Danazol—Convulsion—Thiotepa—sarcoma	0.00129	0.00408	CcSEcCtD
Danazol—Hypertension—Thiotepa—sarcoma	0.00129	0.00407	CcSEcCtD
Danazol—Back pain—Vincristine—sarcoma	0.00128	0.00404	CcSEcCtD
Danazol—Arthralgia—Thiotepa—sarcoma	0.00127	0.00401	CcSEcCtD
Danazol—Anxiety—Thiotepa—sarcoma	0.00126	0.004	CcSEcCtD
Danazol—Back pain—Mitoxantrone—sarcoma	0.00124	0.00394	CcSEcCtD
Danazol—AR—lymph node—sarcoma	0.00122	0.004	CbGeAlD
Danazol—Vision blurred—Mitoxantrone—sarcoma	0.00121	0.00384	CcSEcCtD
Danazol—Oedema—Dactinomycin—sarcoma	0.00121	0.00382	CcSEcCtD
Danazol—Fluid retention—Doxorubicin—sarcoma	0.00121	0.00381	CcSEcCtD
Danazol—ESR1—lymph node—sarcoma	0.0012	0.00393	CbGeAlD
Danazol—Thrombocytopenia—Thiotepa—sarcoma	0.00119	0.00377	CcSEcCtD
Danazol—Vertigo—Vincristine—sarcoma	0.00119	0.00376	CcSEcCtD
Danazol—Tachycardia—Thiotepa—sarcoma	0.00119	0.00375	CcSEcCtD
Danazol—Leukopenia—Vincristine—sarcoma	0.00118	0.00374	CcSEcCtD
Danazol—Thrombocytopenia—Dactinomycin—sarcoma	0.00118	0.00374	CcSEcCtD
Danazol—Erythema multiforme—Etoposide—sarcoma	0.00116	0.00368	CcSEcCtD
Danazol—Leukopenia—Mitoxantrone—sarcoma	0.00115	0.00364	CcSEcCtD
Danazol—Convulsion—Vincristine—sarcoma	0.00114	0.00362	CcSEcCtD
Danazol—Flushing—Etoposide—sarcoma	0.00114	0.00361	CcSEcCtD
Danazol—Hypertension—Vincristine—sarcoma	0.00114	0.00361	CcSEcCtD
Danazol—Hepatic function abnormal—Epirubicin—sarcoma	0.00114	0.00361	CcSEcCtD
Danazol—Photosensitivity—Epirubicin—sarcoma	0.00113	0.00359	CcSEcCtD
Danazol—Convulsion—Mitoxantrone—sarcoma	0.00112	0.00353	CcSEcCtD
Danazol—Hypertension—Mitoxantrone—sarcoma	0.00111	0.00351	CcSEcCtD
Danazol—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00111	0.0035	CcSEcCtD
Danazol—Chills—Etoposide—sarcoma	0.0011	0.00349	CcSEcCtD
Danazol—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.0011	0.00348	CcSEcCtD
Danazol—Arthralgia—Mitoxantrone—sarcoma	0.0011	0.00347	CcSEcCtD
Danazol—Paraesthesia—Thiotepa—sarcoma	0.00109	0.00345	CcSEcCtD
Danazol—Anxiety—Mitoxantrone—sarcoma	0.00109	0.00345	CcSEcCtD
Danazol—Alopecia—Etoposide—sarcoma	0.00109	0.00344	CcSEcCtD
Danazol—Oedema—Vincristine—sarcoma	0.00108	0.00341	CcSEcCtD
Danazol—Dyspepsia—Thiotepa—sarcoma	0.00107	0.00339	CcSEcCtD
Danazol—Thrombocytopenia—Vincristine—sarcoma	0.00106	0.00334	CcSEcCtD
Danazol—Hepatic function abnormal—Doxorubicin—sarcoma	0.00105	0.00334	CcSEcCtD
Danazol—Oedema—Mitoxantrone—sarcoma	0.00105	0.00332	CcSEcCtD
Danazol—Photosensitivity—Doxorubicin—sarcoma	0.00105	0.00332	CcSEcCtD
Danazol—Fatigue—Thiotepa—sarcoma	0.00105	0.00332	CcSEcCtD
Danazol—Hyperhidrosis—Vincristine—sarcoma	0.00104	0.0033	CcSEcCtD
Danazol—Fatigue—Dactinomycin—sarcoma	0.00104	0.00329	CcSEcCtD
Danazol—Constipation—Thiotepa—sarcoma	0.00104	0.00329	CcSEcCtD
Danazol—Back pain—Etoposide—sarcoma	0.00104	0.00328	CcSEcCtD
Danazol—Shock—Mitoxantrone—sarcoma	0.00103	0.00327	CcSEcCtD
Danazol—Muscle spasms—Etoposide—sarcoma	0.00103	0.00326	CcSEcCtD
Danazol—Thrombocytopenia—Mitoxantrone—sarcoma	0.00103	0.00325	CcSEcCtD
Danazol—Tachycardia—Mitoxantrone—sarcoma	0.00103	0.00324	CcSEcCtD
Danazol—Hyperhidrosis—Mitoxantrone—sarcoma	0.00102	0.00321	CcSEcCtD
Danazol—Musculoskeletal discomfort—Vincristine—sarcoma	0.000983	0.00311	CcSEcCtD
Danazol—Migraine—Epirubicin—sarcoma	0.000981	0.0031	CcSEcCtD
Danazol—Affect lability—Epirubicin—sarcoma	0.000981	0.0031	CcSEcCtD
Danazol—Paraesthesia—Vincristine—sarcoma	0.000968	0.00306	CcSEcCtD
Danazol—Urticaria—Thiotepa—sarcoma	0.000966	0.00306	CcSEcCtD
Danazol—Vertigo—Etoposide—sarcoma	0.000962	0.00304	CcSEcCtD
Danazol—Body temperature increased—Thiotepa—sarcoma	0.000961	0.00304	CcSEcCtD
Danazol—Leukopenia—Etoposide—sarcoma	0.000958	0.00303	CcSEcCtD
Danazol—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000957	0.00303	CcSEcCtD
Danazol—Body temperature increased—Dactinomycin—sarcoma	0.000954	0.00302	CcSEcCtD
Danazol—Mood swings—Epirubicin—sarcoma	0.000944	0.00299	CcSEcCtD
Danazol—Paraesthesia—Mitoxantrone—sarcoma	0.000943	0.00298	CcSEcCtD
Danazol—Loss of consciousness—Etoposide—sarcoma	0.000941	0.00298	CcSEcCtD
Danazol—Fatigue—Vincristine—sarcoma	0.00093	0.00294	CcSEcCtD
Danazol—Convulsion—Etoposide—sarcoma	0.000927	0.00293	CcSEcCtD
Danazol—Dyspepsia—Mitoxantrone—sarcoma	0.000925	0.00292	CcSEcCtD
Danazol—Hypertension—Etoposide—sarcoma	0.000924	0.00292	CcSEcCtD
Danazol—Constipation—Vincristine—sarcoma	0.000922	0.00292	CcSEcCtD
Danazol—Abdominal pain upper—Epirubicin—sarcoma	0.00091	0.00288	CcSEcCtD
Danazol—Affect lability—Doxorubicin—sarcoma	0.000907	0.00287	CcSEcCtD
Danazol—Migraine—Doxorubicin—sarcoma	0.000907	0.00287	CcSEcCtD
Danazol—Fatigue—Mitoxantrone—sarcoma	0.000906	0.00286	CcSEcCtD
Danazol—Constipation—Mitoxantrone—sarcoma	0.000898	0.00284	CcSEcCtD
Danazol—Mood swings—Doxorubicin—sarcoma	0.000873	0.00276	CcSEcCtD
Danazol—Asthenia—Thiotepa—sarcoma	0.000873	0.00276	CcSEcCtD
Danazol—CYP3A4—liver—sarcoma	0.00087	0.00286	CbGeAlD
Danazol—Asthenia—Dactinomycin—sarcoma	0.000866	0.00274	CcSEcCtD
Danazol—Pruritus—Thiotepa—sarcoma	0.00086	0.00272	CcSEcCtD
Danazol—Thrombocytopenia—Etoposide—sarcoma	0.000855	0.00271	CcSEcCtD
Danazol—Tachycardia—Etoposide—sarcoma	0.000853	0.0027	CcSEcCtD
Danazol—Eosinophilia—Epirubicin—sarcoma	0.000853	0.0027	CcSEcCtD
Danazol—Body temperature increased—Vincristine—sarcoma	0.000853	0.0027	CcSEcCtD
Danazol—Hyperhidrosis—Etoposide—sarcoma	0.000845	0.00267	CcSEcCtD
Danazol—Pancreatitis—Epirubicin—sarcoma	0.000844	0.00267	CcSEcCtD
Danazol—Abdominal pain upper—Doxorubicin—sarcoma	0.000842	0.00266	CcSEcCtD
Danazol—Urticaria—Mitoxantrone—sarcoma	0.000834	0.00264	CcSEcCtD
Danazol—Body temperature increased—Mitoxantrone—sarcoma	0.00083	0.00263	CcSEcCtD
Danazol—Dizziness—Thiotepa—sarcoma	0.000804	0.00254	CcSEcCtD
Danazol—Eosinophilia—Doxorubicin—sarcoma	0.000789	0.0025	CcSEcCtD
Danazol—Photosensitivity reaction—Epirubicin—sarcoma	0.000786	0.00249	CcSEcCtD
Danazol—Paraesthesia—Etoposide—sarcoma	0.000784	0.00248	CcSEcCtD
Danazol—Weight increased—Epirubicin—sarcoma	0.000784	0.00248	CcSEcCtD
Danazol—Pancreatitis—Doxorubicin—sarcoma	0.000781	0.00247	CcSEcCtD
Danazol—Asthenia—Vincristine—sarcoma	0.000774	0.00245	CcSEcCtD
Danazol—Vomiting—Thiotepa—sarcoma	0.000773	0.00245	CcSEcCtD
Danazol—Vomiting—Dactinomycin—sarcoma	0.000767	0.00243	CcSEcCtD
Danazol—Rash—Thiotepa—sarcoma	0.000767	0.00243	CcSEcCtD
Danazol—Dermatitis—Thiotepa—sarcoma	0.000766	0.00242	CcSEcCtD
Danazol—Headache—Thiotepa—sarcoma	0.000762	0.00241	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000761	0.00241	CcSEcCtD
Danazol—Rash—Dactinomycin—sarcoma	0.000761	0.00241	CcSEcCtD
Danazol—Asthenia—Mitoxantrone—sarcoma	0.000754	0.00238	CcSEcCtD
Danazol—Fatigue—Etoposide—sarcoma	0.000753	0.00238	CcSEcCtD
Danazol—Jaundice—Epirubicin—sarcoma	0.000748	0.00237	CcSEcCtD
Danazol—Constipation—Etoposide—sarcoma	0.000747	0.00236	CcSEcCtD
Danazol—Sweating—Epirubicin—sarcoma	0.000736	0.00233	CcSEcCtD
Danazol—Haematuria—Epirubicin—sarcoma	0.000732	0.00232	CcSEcCtD
Danazol—Photosensitivity reaction—Doxorubicin—sarcoma	0.000727	0.0023	CcSEcCtD
Danazol—Weight increased—Doxorubicin—sarcoma	0.000725	0.00229	CcSEcCtD
Danazol—Nausea—Thiotepa—sarcoma	0.000722	0.00229	CcSEcCtD
Danazol—Nausea—Dactinomycin—sarcoma	0.000717	0.00227	CcSEcCtD
Danazol—Dizziness—Vincristine—sarcoma	0.000713	0.00226	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000704	0.00223	CcSEcCtD
Danazol—Urticaria—Etoposide—sarcoma	0.000694	0.0022	CcSEcCtD
Danazol—Haemoglobin—Epirubicin—sarcoma	0.000693	0.00219	CcSEcCtD
Danazol—Jaundice—Doxorubicin—sarcoma	0.000693	0.00219	CcSEcCtD
Danazol—Body temperature increased—Etoposide—sarcoma	0.000691	0.00218	CcSEcCtD
Danazol—Haemorrhage—Epirubicin—sarcoma	0.000689	0.00218	CcSEcCtD
Danazol—Vomiting—Vincristine—sarcoma	0.000686	0.00217	CcSEcCtD
Danazol—Sweating—Doxorubicin—sarcoma	0.000681	0.00215	CcSEcCtD
Danazol—Rash—Vincristine—sarcoma	0.00068	0.00215	CcSEcCtD
Danazol—Dermatitis—Vincristine—sarcoma	0.000679	0.00215	CcSEcCtD
Danazol—Haematuria—Doxorubicin—sarcoma	0.000677	0.00214	CcSEcCtD
Danazol—Headache—Vincristine—sarcoma	0.000676	0.00214	CcSEcCtD
Danazol—Vomiting—Mitoxantrone—sarcoma	0.000668	0.00211	CcSEcCtD
Danazol—Visual impairment—Epirubicin—sarcoma	0.000664	0.0021	CcSEcCtD
Danazol—Rash—Mitoxantrone—sarcoma	0.000662	0.00209	CcSEcCtD
Danazol—Dermatitis—Mitoxantrone—sarcoma	0.000662	0.00209	CcSEcCtD
Danazol—Headache—Mitoxantrone—sarcoma	0.000658	0.00208	CcSEcCtD
Danazol—Erythema multiforme—Epirubicin—sarcoma	0.000652	0.00206	CcSEcCtD
Danazol—Haemoglobin—Doxorubicin—sarcoma	0.000641	0.00203	CcSEcCtD
Danazol—Nausea—Vincristine—sarcoma	0.000641	0.00203	CcSEcCtD
Danazol—Flushing—Epirubicin—sarcoma	0.00064	0.00202	CcSEcCtD
Danazol—Haemorrhage—Doxorubicin—sarcoma	0.000638	0.00202	CcSEcCtD
Danazol—ESR1—ATF-2 transcription factor network—JUN—sarcoma	0.000633	0.00183	CbGpPWpGaD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—KRAS—sarcoma	0.000629	0.00182	CbGpPWpGaD
Danazol—Asthenia—Etoposide—sarcoma	0.000627	0.00198	CcSEcCtD
Danazol—Nausea—Mitoxantrone—sarcoma	0.000624	0.00197	CcSEcCtD
Danazol—PGR—Gene Expression—FUS—sarcoma	0.000623	0.0018	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—MYC—sarcoma	0.000621	0.0018	CbGpPWpGaD
Danazol—Chills—Epirubicin—sarcoma	0.000618	0.00196	CcSEcCtD
Danazol—Pruritus—Etoposide—sarcoma	0.000618	0.00196	CcSEcCtD
Danazol—Visual impairment—Doxorubicin—sarcoma	0.000615	0.00194	CcSEcCtD
Danazol—Alopecia—Epirubicin—sarcoma	0.000609	0.00193	CcSEcCtD
Danazol—ESR1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	0.000607	0.00176	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000605	0.00175	CbGpPWpGaD
Danazol—Erythema multiforme—Doxorubicin—sarcoma	0.000603	0.00191	CcSEcCtD
Danazol—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	0.000594	0.00172	CbGpPWpGaD
Danazol—ESR1—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	0.000593	0.00172	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—CCND1—sarcoma	0.000593	0.00172	CbGpPWpGaD
Danazol—Flushing—Doxorubicin—sarcoma	0.000592	0.00187	CcSEcCtD
Danazol—AR—Androgen receptor signaling pathway—JUN—sarcoma	0.000591	0.00171	CbGpPWpGaD
Danazol—Tension—Epirubicin—sarcoma	0.000589	0.00186	CcSEcCtD
Danazol—AR—Androgen receptor signaling pathway—CTNNB1—sarcoma	0.000587	0.0017	CbGpPWpGaD
Danazol—Nervousness—Epirubicin—sarcoma	0.000583	0.00184	CcSEcCtD
Danazol—PGR—Signaling by ERBB4—MDM2—sarcoma	0.000582	0.00168	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—IL2—sarcoma	0.000581	0.00168	CbGpPWpGaD
Danazol—Back pain—Epirubicin—sarcoma	0.00058	0.00184	CcSEcCtD
Danazol—Dizziness—Etoposide—sarcoma	0.000578	0.00183	CcSEcCtD
Danazol—Muscle spasms—Epirubicin—sarcoma	0.000577	0.00182	CcSEcCtD
Danazol—ESR1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	0.000574	0.00166	CbGpPWpGaD
Danazol—Chills—Doxorubicin—sarcoma	0.000572	0.00181	CcSEcCtD
Danazol—ESR1—Integrated Breast Cancer Pathway—FOXO1—sarcoma	0.000572	0.00166	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—FOXO1—sarcoma	0.000569	0.00165	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—PDGFRB—sarcoma	0.000568	0.00164	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL2—sarcoma	0.000567	0.00164	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—CCND1—sarcoma	0.000566	0.00164	CbGpPWpGaD
Danazol—Vision blurred—Epirubicin—sarcoma	0.000566	0.00179	CcSEcCtD
Danazol—ESR1—Regulation of Telomerase—JUN—sarcoma	0.000565	0.00164	CbGpPWpGaD
Danazol—Alopecia—Doxorubicin—sarcoma	0.000564	0.00178	CcSEcCtD
Danazol—ESR1—Signaling by ERBB4—PDGFRA—sarcoma	0.000559	0.00162	CbGpPWpGaD
Danazol—Vomiting—Etoposide—sarcoma	0.000555	0.00176	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—CCND1—sarcoma	0.000553	0.0016	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—JUN—sarcoma	0.000552	0.0016	CbGpPWpGaD
Danazol—Rash—Etoposide—sarcoma	0.000551	0.00174	CcSEcCtD
Danazol—Dermatitis—Etoposide—sarcoma	0.00055	0.00174	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—CTNNB1—sarcoma	0.000548	0.00159	CbGpPWpGaD
Danazol—Headache—Etoposide—sarcoma	0.000547	0.00173	CcSEcCtD
Danazol—Tension—Doxorubicin—sarcoma	0.000545	0.00172	CcSEcCtD
Danazol—Nervousness—Doxorubicin—sarcoma	0.000539	0.00171	CcSEcCtD
Danazol—Vertigo—Epirubicin—sarcoma	0.000539	0.00171	CcSEcCtD
Danazol—AR—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.000539	0.00156	CbGpPWpGaD
Danazol—ESR1—LKB1 signaling events—TP53—sarcoma	0.000538	0.00156	CbGpPWpGaD
Danazol—Syncope—Epirubicin—sarcoma	0.000538	0.0017	CcSEcCtD
Danazol—Leukopenia—Epirubicin—sarcoma	0.000537	0.0017	CcSEcCtD
Danazol—Back pain—Doxorubicin—sarcoma	0.000537	0.0017	CcSEcCtD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—HRAS—sarcoma	0.000535	0.00155	CbGpPWpGaD
Danazol—Muscle spasms—Doxorubicin—sarcoma	0.000534	0.00169	CcSEcCtD
Danazol—AR—Androgen receptor signaling pathway—SRC—sarcoma	0.00053	0.00154	CbGpPWpGaD
Danazol—Palpitations—Epirubicin—sarcoma	0.00053	0.00168	CcSEcCtD
Danazol—Loss of consciousness—Epirubicin—sarcoma	0.000527	0.00167	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000525	0.00152	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	0.000525	0.00152	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—CCND1—sarcoma	0.000524	0.00152	CbGpPWpGaD
Danazol—Vision blurred—Doxorubicin—sarcoma	0.000523	0.00166	CcSEcCtD
Danazol—Convulsion—Epirubicin—sarcoma	0.00052	0.00164	CcSEcCtD
Danazol—Nausea—Etoposide—sarcoma	0.000519	0.00164	CcSEcCtD
Danazol—Hypertension—Epirubicin—sarcoma	0.000518	0.00164	CcSEcCtD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—sarcoma	0.000518	0.0015	CbGpPWpGaD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	0.000513	0.00148	CbGpPWpGaD
Danazol—Arthralgia—Epirubicin—sarcoma	0.000511	0.00162	CcSEcCtD
Danazol—Anxiety—Epirubicin—sarcoma	0.000509	0.00161	CcSEcCtD
Danazol—GNRHR—GPCR downstream signaling—CXCR4—sarcoma	0.000503	0.00146	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CXCR4—sarcoma	0.000499	0.00144	CbGpPWpGaD
Danazol—Vertigo—Doxorubicin—sarcoma	0.000499	0.00158	CcSEcCtD
Danazol—Syncope—Doxorubicin—sarcoma	0.000498	0.00157	CcSEcCtD
Danazol—Leukopenia—Doxorubicin—sarcoma	0.000497	0.00157	CcSEcCtD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	0.000491	0.00142	CbGpPWpGaD
Danazol—Palpitations—Doxorubicin—sarcoma	0.000491	0.00155	CcSEcCtD
Danazol—Oedema—Epirubicin—sarcoma	0.00049	0.00155	CcSEcCtD
Danazol—Loss of consciousness—Doxorubicin—sarcoma	0.000488	0.00154	CcSEcCtD
Danazol—ESR1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	0.000488	0.00141	CbGpPWpGaD
Danazol—Shock—Epirubicin—sarcoma	0.000482	0.00152	CcSEcCtD
Danazol—Convulsion—Doxorubicin—sarcoma	0.000481	0.00152	CcSEcCtD
Danazol—Thrombocytopenia—Epirubicin—sarcoma	0.000479	0.00152	CcSEcCtD
Danazol—Hypertension—Doxorubicin—sarcoma	0.000479	0.00152	CcSEcCtD
Danazol—Tachycardia—Epirubicin—sarcoma	0.000478	0.00151	CcSEcCtD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	0.000478	0.00138	CbGpPWpGaD
Danazol—ESR1—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	0.000477	0.00138	CbGpPWpGaD
Danazol—AR—Gene Expression—FUS—sarcoma	0.000475	0.00137	CbGpPWpGaD
Danazol—Hyperhidrosis—Epirubicin—sarcoma	0.000473	0.0015	CcSEcCtD
Danazol—Arthralgia—Doxorubicin—sarcoma	0.000473	0.0015	CcSEcCtD
Danazol—Anxiety—Doxorubicin—sarcoma	0.000471	0.00149	CcSEcCtD
Danazol—ESR1—Leptin signaling pathway—SRC—sarcoma	0.000469	0.00136	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000466	0.00135	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—EGFR—sarcoma	0.000465	0.00135	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.000464	0.00134	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TLE1—sarcoma	0.000463	0.00134	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CXCR4—sarcoma	0.000457	0.00132	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—MYC—sarcoma	0.000454	0.00131	CbGpPWpGaD
Danazol—Oedema—Doxorubicin—sarcoma	0.000453	0.00143	CcSEcCtD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	0.000451	0.00131	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000446	0.00129	CbGpPWpGaD
Danazol—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000446	0.00141	CcSEcCtD
Danazol—Shock—Doxorubicin—sarcoma	0.000446	0.00141	CcSEcCtD
Danazol—AR—Integrated Breast Cancer Pathway—MDM2—sarcoma	0.000446	0.00129	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—EGFR—sarcoma	0.000444	0.00129	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—MYC—sarcoma	0.000444	0.00128	CbGpPWpGaD
Danazol—Thrombocytopenia—Doxorubicin—sarcoma	0.000444	0.0014	CcSEcCtD
Danazol—Tachycardia—Doxorubicin—sarcoma	0.000442	0.0014	CcSEcCtD
Danazol—Paraesthesia—Epirubicin—sarcoma	0.00044	0.00139	CcSEcCtD
Danazol—Hyperhidrosis—Doxorubicin—sarcoma	0.000438	0.00139	CcSEcCtD
Danazol—PGR—Signaling by ERBB4—NRAS—sarcoma	0.000437	0.00126	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—KIT—sarcoma	0.000434	0.00126	CbGpPWpGaD
Danazol—Dyspepsia—Epirubicin—sarcoma	0.000431	0.00136	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—TLE1—sarcoma	0.000423	0.00123	CbGpPWpGaD
Danazol—Fatigue—Epirubicin—sarcoma	0.000422	0.00134	CcSEcCtD
Danazol—Constipation—Epirubicin—sarcoma	0.000419	0.00132	CcSEcCtD
Danazol—ESR1—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.000415	0.0012	CbGpPWpGaD
Danazol—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000413	0.00131	CcSEcCtD
Danazol—ESR1—Signaling by ERBB4—CREB1—sarcoma	0.000413	0.00119	CbGpPWpGaD
Danazol—Paraesthesia—Doxorubicin—sarcoma	0.000407	0.00129	CcSEcCtD
Danazol—Dyspepsia—Doxorubicin—sarcoma	0.000399	0.00126	CcSEcCtD
Danazol—PGR—Signaling by ERBB4—EGFR—sarcoma	0.000398	0.00115	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	0.000395	0.00114	CbGpPWpGaD
Danazol—Fatigue—Doxorubicin—sarcoma	0.000391	0.00124	CcSEcCtD
Danazol—CCL2—Signaling Pathways—VEGFC—sarcoma	0.000391	0.00113	CbGpPWpGaD
Danazol—Urticaria—Epirubicin—sarcoma	0.000389	0.00123	CcSEcCtD
Danazol—AR—Integrated Breast Cancer Pathway—CCND1—sarcoma	0.000388	0.00112	CbGpPWpGaD
Danazol—Constipation—Doxorubicin—sarcoma	0.000387	0.00123	CcSEcCtD
Danazol—AR—Integrated Breast Cancer Pathway—JUN—sarcoma	0.000387	0.00112	CbGpPWpGaD
Danazol—Body temperature increased—Epirubicin—sarcoma	0.000387	0.00122	CcSEcCtD
Danazol—AR—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	0.000384	0.00111	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	0.000384	0.00111	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—MDM2—sarcoma	0.000384	0.00111	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—JUN—sarcoma	0.000377	0.00109	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—KRAS—sarcoma	0.000376	0.00109	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000375	0.00108	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000369	0.00107	CbGpPWpGaD
Danazol—ESR1—Gene Expression—FUS—sarcoma	0.000366	0.00106	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—TP53—sarcoma	0.000364	0.00105	CbGpPWpGaD
Danazol—Urticaria—Doxorubicin—sarcoma	0.00036	0.00114	CcSEcCtD
Danazol—Body temperature increased—Doxorubicin—sarcoma	0.000358	0.00113	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—VEGFC—sarcoma	0.000357	0.00103	CbGpPWpGaD
Danazol—Asthenia—Epirubicin—sarcoma	0.000351	0.00111	CcSEcCtD
Danazol—Pruritus—Epirubicin—sarcoma	0.000346	0.0011	CcSEcCtD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000344	0.000995	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—MDM2—sarcoma	0.000343	0.000994	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—MDM2—sarcoma	0.000342	0.000989	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—MMP2—sarcoma	0.000341	0.000988	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—VEGFA—sarcoma	0.000338	0.00098	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CCND1—sarcoma	0.000334	0.000967	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—JUN—sarcoma	0.000333	0.000965	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	0.000331	0.000958	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—HRAS—sarcoma	0.00033	0.000955	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.00033	0.000954	CbGpPWpGaD
Danazol—Asthenia—Doxorubicin—sarcoma	0.000325	0.00103	CcSEcCtD
Danazol—Dizziness—Epirubicin—sarcoma	0.000324	0.00102	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000322	0.000931	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000321	0.000929	CbGpPWpGaD
Danazol—Pruritus—Doxorubicin—sarcoma	0.000321	0.00101	CcSEcCtD
Danazol—PGR—Signaling by ERBB4—HRAS—sarcoma	0.000319	0.000924	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000319	0.000922	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—FLT1—sarcoma	0.000312	0.000904	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—MYC—sarcoma	0.000311	0.000901	CbGpPWpGaD
Danazol—Vomiting—Epirubicin—sarcoma	0.000311	0.000985	CcSEcCtD
Danazol—Rash—Epirubicin—sarcoma	0.000309	0.000977	CcSEcCtD
Danazol—Dermatitis—Epirubicin—sarcoma	0.000308	0.000976	CcSEcCtD
Danazol—CCL2—Signaling Pathways—PLCG1—sarcoma	0.000307	0.000888	CbGpPWpGaD
Danazol—Headache—Epirubicin—sarcoma	0.000307	0.00097	CcSEcCtD
Danazol—AR—Integrated Breast Cancer Pathway—EGFR—sarcoma	0.000305	0.000882	CbGpPWpGaD
Danazol—Dizziness—Doxorubicin—sarcoma	0.0003	0.000948	CcSEcCtD
Danazol—ESR1—Integrated Breast Cancer Pathway—CCND1—sarcoma	0.000299	0.000866	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—JUN—sarcoma	0.000298	0.000864	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	0.000296	0.000857	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CXCR4—sarcoma	0.000295	0.000854	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ATF1—sarcoma	0.000292	0.000844	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	0.000291	0.000843	CbGpPWpGaD
Danazol—Nausea—Epirubicin—sarcoma	0.000291	0.00092	CcSEcCtD
Danazol—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.00029	0.000838	CbGpPWpGaD
Danazol—Vomiting—Doxorubicin—sarcoma	0.000288	0.000911	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000288	0.000833	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—KRAS—sarcoma	0.000288	0.000833	CbGpPWpGaD
Danazol—Rash—Doxorubicin—sarcoma	0.000286	0.000904	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—FLT1—sarcoma	0.000286	0.000827	CbGpPWpGaD
Danazol—Dermatitis—Doxorubicin—sarcoma	0.000285	0.000903	CcSEcCtD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000285	0.000823	CbGpPWpGaD
Danazol—Headache—Doxorubicin—sarcoma	0.000284	0.000898	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—PLCG1—sarcoma	0.000281	0.000813	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.00028	0.000812	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CXCR4—sarcoma	0.00027	0.000781	CbGpPWpGaD
Danazol—Nausea—Doxorubicin—sarcoma	0.000269	0.000851	CcSEcCtD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—MYC—sarcoma	0.000268	0.000776	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CREB1—sarcoma	0.000267	0.000774	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TLE1—sarcoma	0.000267	0.000773	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ATF1—sarcoma	0.000267	0.000772	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—EGFR—sarcoma	0.000262	0.000759	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—CTNNB1—sarcoma	0.000262	0.000757	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	0.000261	0.000755	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000258	0.000747	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—NRAS—sarcoma	0.000256	0.000741	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—TP53—sarcoma	0.000256	0.00074	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000252	0.000731	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000248	0.000717	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—KRAS—sarcoma	0.000248	0.000717	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000247	0.000716	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000245	0.00071	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CREB1—sarcoma	0.000245	0.000708	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—MYC—sarcoma	0.00024	0.000694	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000238	0.00069	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—EGFR—sarcoma	0.000235	0.000679	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—EGFR—sarcoma	0.000233	0.000676	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IGF1R—sarcoma	0.000229	0.000662	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFC—sarcoma	0.000225	0.000652	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000222	0.000642	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—KRAS—sarcoma	0.000222	0.000642	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—KRAS—sarcoma	0.00022	0.000638	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—TP53—sarcoma	0.00022	0.000637	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—FOXO1—sarcoma	0.000218	0.00063	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PDGFRB—sarcoma	0.000217	0.000629	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000216	0.000625	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PDGFRA—sarcoma	0.000214	0.000619	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000212	0.000613	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IGF1R—sarcoma	0.000209	0.000606	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—FOXO1—sarcoma	0.000199	0.000577	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—IL2—sarcoma	0.000199	0.000576	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PDGFRB—sarcoma	0.000199	0.000576	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000199	0.000575	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL2—sarcoma	0.000198	0.000572	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—TP53—sarcoma	0.000197	0.00057	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PDGFRA—sarcoma	0.000196	0.000567	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000194	0.000563	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—HRAS—sarcoma	0.000187	0.000542	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000184	0.000532	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL2—sarcoma	0.000181	0.000523	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KDR—sarcoma	0.00018	0.000521	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FLT1—sarcoma	0.00018	0.000521	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PLCG1—sarcoma	0.000177	0.000512	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCR4—sarcoma	0.00017	0.000492	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—MYC—sarcoma	0.000168	0.000487	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ATF1—sarcoma	0.000168	0.000487	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KIT—sarcoma	0.000166	0.00048	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—NRAS—sarcoma	0.000166	0.00048	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KDR—sarcoma	0.000165	0.000477	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ENO2—sarcoma	0.000164	0.000473	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000163	0.000472	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—HBA1—sarcoma	0.000163	0.00047	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CREB1—sarcoma	0.000158	0.000457	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TLE1—sarcoma	0.000157	0.000454	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KIT—sarcoma	0.000152	0.000439	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—NRAS—sarcoma	0.000152	0.000439	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—EGFR—sarcoma	0.000151	0.000438	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CREB1—sarcoma	0.000144	0.000418	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—KRAS—sarcoma	0.000143	0.000413	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PLCG1—sarcoma	0.000139	0.000402	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—EGFR—sarcoma	0.000138	0.0004	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFC—sarcoma	0.000132	0.000383	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF1R—sarcoma	0.000132	0.000382	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MDM2—sarcoma	0.000131	0.000378	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—KRAS—sarcoma	0.000131	0.000378	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—MYC—sarcoma	0.000128	0.000371	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FOXO1—sarcoma	0.000126	0.000364	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PDGFRB—sarcoma	0.000125	0.000363	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PDGFRA—sarcoma	0.000123	0.000357	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—HRAS—sarcoma	0.000121	0.000351	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MDM2—sarcoma	0.00012	0.000346	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL2—sarcoma	0.000117	0.000338	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCND1—sarcoma	0.000114	0.000329	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—JUN—sarcoma	0.000114	0.000329	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CTNNB1—sarcoma	0.000113	0.000326	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—HRAS—sarcoma	0.000111	0.000321	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL2—sarcoma	0.000107	0.000309	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FLT1—sarcoma	0.000106	0.000306	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCND1—sarcoma	0.000104	0.000301	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PLCG1—sarcoma	0.000104	0.000301	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KDR—sarcoma	0.000104	0.000301	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—JUN—sarcoma	0.000104	0.000301	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CTNNB1—sarcoma	0.000103	0.000298	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SRC—sarcoma	0.000102	0.000295	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCR4—sarcoma	9.98e-05	0.000289	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—sarcoma	9.92e-05	0.000287	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—MYC—sarcoma	9.87e-05	0.000286	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ATF1—sarcoma	9.87e-05	0.000286	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NRAS—sarcoma	9.8e-05	0.000284	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KIT—sarcoma	9.57e-05	0.000277	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SRC—sarcoma	9.32e-05	0.00027	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MYC—sarcoma	9.13e-05	0.000264	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CREB1—sarcoma	9.11e-05	0.000264	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—sarcoma	9.08e-05	0.000263	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NRAS—sarcoma	8.97e-05	0.00026	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EGFR—sarcoma	8.93e-05	0.000259	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KRAS—sarcoma	8.44e-05	0.000244	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MYC—sarcoma	8.35e-05	0.000242	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EGFR—sarcoma	8.17e-05	0.000236	CbGpPWpGaD
Danazol—PGR—Gene Expression—MYC—sarcoma	8.1e-05	0.000234	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF1R—sarcoma	7.75e-05	0.000224	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KRAS—sarcoma	7.72e-05	0.000223	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MDM2—sarcoma	7.54e-05	0.000218	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—sarcoma	7.5e-05	0.000217	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FOXO1—sarcoma	7.37e-05	0.000213	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PDGFRB—sarcoma	7.36e-05	0.000213	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PDGFRA—sarcoma	7.24e-05	0.00021	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HRAS—sarcoma	7.17e-05	0.000208	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—sarcoma	6.86e-05	0.000199	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL2—sarcoma	6.74e-05	0.000195	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCND1—sarcoma	6.57e-05	0.00019	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HRAS—sarcoma	6.56e-05	0.00019	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—JUN—sarcoma	6.55e-05	0.00019	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CTNNB1—sarcoma	6.5e-05	0.000188	CbGpPWpGaD
Danazol—AR—Gene Expression—MYC—sarcoma	6.17e-05	0.000179	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KDR—sarcoma	6.1e-05	0.000176	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SRC—sarcoma	5.88e-05	0.00017	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—sarcoma	5.72e-05	0.000166	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NRAS—sarcoma	5.65e-05	0.000164	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KIT—sarcoma	5.62e-05	0.000163	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CREB1—sarcoma	5.35e-05	0.000155	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MYC—sarcoma	5.27e-05	0.000152	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EGFR—sarcoma	5.15e-05	0.000149	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KRAS—sarcoma	4.87e-05	0.000141	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ENO2—sarcoma	4.77e-05	0.000138	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MYC—sarcoma	4.75e-05	0.000138	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HBA1—sarcoma	4.74e-05	0.000137	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MDM2—sarcoma	4.42e-05	0.000128	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—sarcoma	4.33e-05	0.000125	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HRAS—sarcoma	4.14e-05	0.00012	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PLCG1—sarcoma	4.05e-05	0.000117	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL2—sarcoma	3.95e-05	0.000114	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCND1—sarcoma	3.85e-05	0.000112	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—JUN—sarcoma	3.85e-05	0.000111	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CTNNB1—sarcoma	3.82e-05	0.00011	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SRC—sarcoma	3.45e-05	9.98e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—sarcoma	3.36e-05	9.72e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NRAS—sarcoma	3.32e-05	9.6e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MYC—sarcoma	3.09e-05	8.95e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EGFR—sarcoma	3.02e-05	8.75e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KRAS—sarcoma	2.86e-05	8.27e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—sarcoma	2.54e-05	7.35e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HRAS—sarcoma	2.43e-05	7.03e-05	CbGpPWpGaD
